Prospective associations between hsCRP and GlycA inflammatory biomarkers and depression: The Brazilian longitudinal study of adult health (ELSA-Brasil).

[1]  D. Jacobs,et al.  GlycA, a composite low‐grade inflammatory marker, predicts mortality: prime time for utilization? , 2019, Journal of internal medicine.

[2]  M. Berk,et al.  Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders , 2019, Front. Psychiatry.

[3]  B. Penninx,et al.  Longitudinal Association Between Depression and Inflammatory Markers: Results From the Netherlands Study of Depression and Anxiety , 2019, Biological Psychiatry.

[4]  A. Zonderman,et al.  Systemic inflammation is associated with depressive symptoms differentially by sex and race: a longitudinal study of urban adults , 2019, Molecular Psychiatry.

[5]  Peter B. Jones,et al.  Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort , 2019, bioRxiv.

[6]  E. Bullmore.  Inflamed depression , 2018, The Lancet.

[7]  D. Dietrich,et al.  Alterations of the serum N-glycan profile in female patients with Major Depressive Disorder. , 2018, Journal of affective disorders.

[8]  Peter B. Jones,et al.  Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort , 2017, Brain, Behavior, and Immunity.

[9]  M. Connelly,et al.  GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk , 2017, Journal of Translational Medicine.

[10]  E. Bullmore,et al.  Treatment-resistant depression and peripheral C-reactive protein , 2017, bioRxiv.

[11]  M. Strippoli,et al.  Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study , 2017, Psychological Medicine.

[12]  Michael E. Hall,et al.  Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil) , 2017, Journal of the American Heart Association.

[13]  M. Maes,et al.  Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis , 2017, Molecular Neurobiology.

[14]  C. Pariante.  Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation , 2017, European Neuropsychopharmacology.

[15]  A. Carvalho,et al.  Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies , 2017, Acta psychiatrica Scandinavica.

[16]  A. Carvalho,et al.  C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. , 2016, The lancet. Psychiatry.

[17]  Steven P Jones,et al.  Abstract 14415: GlycA Is Associated With Coronary Artery Calcium Above and Beyond C-reactive Protein. The Brazilian Longitudinal Study of Adult Health (ELSA Brasil) , 2016 .

[18]  M. Connelly,et al.  Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[19]  C. Nagel,et al.  Inconsistency in the Self-report of Chronic Diseases in Panel Surveys: Developing an Adjudication Method for the Health and Retirement Study , 2016, The journals of gerontology. Series B, Psychological sciences and social sciences.

[20]  M. Connelly,et al.  GlycA, a novel marker of inflammation, is elevated in systemic lupus erythematosus , 2016, Lupus.

[21]  A. Carvalho,et al.  Bias in Peripheral Depression Biomarkers , 2016, Psychotherapy and Psychosomatics.

[22]  I. Benseñor,et al.  Sodium and potassium intake estimated using two methods in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) , 2015, Sao Paulo medical journal = Revista paulista de medicina.

[23]  Liam G. Fearnley,et al.  The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. , 2015, Cell systems.

[24]  A. Danese,et al.  Inflammation and clinical response to treatment in depression: A meta-analysis , 2015, European Neuropsychopharmacology.

[25]  P. Ridker,et al.  Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[26]  M. Connelly,et al.  Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis , 2015, Arthritis Research & Therapy.

[27]  M. Connelly,et al.  GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. , 2015, Clinical chemistry.

[28]  M. Maes,et al.  Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass , 2014, Molecular Psychiatry.

[29]  P. Ridker,et al.  A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events , 2014, Journal of the American Heart Association.

[30]  B. Nordestgaard,et al.  Elevated C-Reactive Protein, Depression, Somatic Diseases, and All-Cause Mortality: A Mendelian Randomization Study , 2014, Biological Psychiatry.

[31]  B. Duncan,et al.  Cohort Profile Cohort Profile : Longitudinal Study of Adult Health ( ELSA-Brasil ) , 2015 .

[32]  I. Benseñor,et al.  Patterns of benzodiazepine and antidepressant use among middle-aged adults. the Brazilian longitudinal study of adult health (ELSA-Brasil). , 2013, Journal of affective disorders.

[33]  Klaus P. Ebmeier,et al.  CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. , 2013, Journal of affective disorders.

[34]  Dóra Chor,et al.  Questionario do ELSA-Brasil: desafios na elaboracao de instrumento multidimensional , 2013 .

[35]  M. Nunes,et al.  Recrutamento de participantes no Estudo Longitudinal de Saude do Adulto , 2013 .

[36]  M. C. B. Molina,et al.  Estratégias e desenvolvimento de garantia e controle de qualidade no ELSA-Brasil , 2013 .

[37]  Claes Wahlestedt,et al.  Personalized medicine in psychiatry: problems and promises , 2013, BMC Medicine.

[38]  Moyses Szklo,et al.  American Journal of Epidemiology Practice of Epidemiology Brazilian Longitudinal Study of Adult Health (elsa-brasil): Objectives and Design , 2022 .

[39]  M. Alves,et al.  Adaptação transcultural do CIS-R (Clinical Interview Schedule - Revised Version) para o português no estudo longitudinal de saúde do adulto (ELSA) , 2012 .

[40]  B. Leonard,et al.  Association of high-sensitivity C-reactive protein with de novo major depression , 2010, British Journal of Psychiatry.

[41]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[42]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[43]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[44]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[45]  W. Cromwell,et al.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. , 2006, Clinics in laboratory medicine.

[46]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[47]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[48]  J. Twisk,et al.  Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide , 2003 .

[49]  P. Ridker,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[50]  N. Taub,et al.  Cross validation of a general population survey diagnostic interview: a comparison of CIS-R with SCAN ICD-10 diagnostic categories , 1999, Psychological Medicine.

[51]  M Tansella,et al.  Efficacy of the alcohol use disorders identification test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study , 1997, BMJ.

[52]  G Lewis,et al.  Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers , 1992, Psychological Medicine.

[53]  T. Brugha,et al.  SCAN. Schedules for Clinical Assessment in Neuropsychiatry. , 1990, Archives of general psychiatry.

[54]  G. Strecker,et al.  Determination of the primary structures of 16 asialo-carbohydrate units derived from human plasma α1-acid glycoprotein by 360-MHz 1H NMR spectroscopy and permethylation analysis , 1978 .

[55]  D. F. Drake,et al.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.